ALNYLAM PHARMACEUTICALS, INC.
Proposal 1a.
Election of Class II Director to serve a term until 2027: Dennis A. Ausiello, M.D.
Caisse vote:
For
Applicable policy or principle:
PC_00
Proposal 1b.
Election of Class II Director to serve a term until 2027: Olivier Brandicourt, M.D.
Caisse vote:
For
Applicable policy or principle:
PC_00
Proposal 1c.
Election of Class II Director to serve a term until 2027: Peter N. Kellogg
Caisse vote:
For
Applicable policy or principle:
PC_00
Proposal 1d.
Election of Class II Director to serve a term until 2027: David E.I. Pyott
Caisse vote:
For
Applicable policy or principle:
PC_00
Proposal 2.
To approve, in a non-binding advisory vote, the compensation of Alnylam's named executive officers.
Caisse vote:
For
Applicable policy or principle:
PC_00
Proposal 3.
To ratify the appointment of PricewaterhouseCoopers LLP, an independent registered public accounting firm, as Alnylam's independent auditors for the fiscal year ending December 31, 2024.
Caisse vote:
For
Applicable policy or principle:
PC_00